This report summarizes MTaPS’ strategic approach, key achievements, and results in Nepal to strengthen pharmaceutical-sector governance and the Department of Drug Administration’s (DDA) regulatory capacity, to […]
Read MoreCôte d’Ivoire, like many other countries, is grappling with high rates of health care–associated infections (HCAI) and antimicrobial resistance (AMR). Strong drug and therapeutic committees (DTCs) […]
Read MoreThis report summarizes the MTaPS’ strategic approach, key achievements, and results to prevent and contain antimicrobial resistance in Ethiopia through multisectoral coordination, infection prevention and control, […]
Read More